Filana Therapeutics (MEX:FLNA) Cyclically Adjusted Book per Share: MXN66.65 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:FLNA Filana Therapeutics Inc MEX:FLNA
32 GF Score
Price MXN15.92
! 1 Warning Sign
View Full Analysis

What is Filana Therapeutics Cyclically Adjusted Book per Share?

Filana Therapeutics MEX:FLNA 32 Cyclically Adjusted Book per Share is MXN66.65 as of Jun. 2026. GuruFocus rates MEX:FLNA with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Filana Therapeutics's adjusted book value per share for the three months ended in Jun. 2026 was MXN23.008. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN66.65 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Filana Therapeutics's average Cyclically Adjusted Book Growth Rate was -8.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -6.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -2.60% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Filana Therapeutics was 2.40% per year. The lowest was -23.20% per year. And the median was -7.50% per year.

As of today (2026-09-16), Filana Therapeutics's current stock price is MXN15.92. Filana Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was MXN66.65. Filana Therapeutics's Cyclically Adjusted PB Ratio of today is 0.24.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Filana Therapeutics was 0.23. The lowest was 0.00. And the median was 0.00.


Filana Therapeutics  (MEX:FLNA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Filana Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=15.92/66.648
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Filana Therapeutics was 0.23. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Filana Therapeutics Cyclically Adjusted Book per Share Related Terms


Filana Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Filana Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Filana Therapeutics Cyclically Adjusted Book per Share Chart

Filana Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.82 79.42 74.78 71.09 65.13

Filana Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.67 70.02 67.89 67.54 66.65

MEX:FLNA vs EDSA, GRCE, VERU: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Filana Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Filana Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Filana Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Filana Therapeutics's Cyclically Adjusted PB Ratio falls into.


MEX:FLNA
32GF Score
Filana Therapeutics Inc MEX:FLNA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Filana Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Filana Therapeutics's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=23.008/333.9520*333.9520
=23.008

Current CPI (Jun. 2026) = 333.9520.

Filana Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201609 59.646 241.428 82.505
201612 58.247 241.432 80.568
201703 47.776 243.801 65.442
201706 36.416 244.955 49.647
201709 31.296 246.819 42.344
201712 28.772 246.524 38.976
201803 27.266 249.554 36.487
201806 24.360 251.989 32.283
201809 21.691 252.439 28.695
201812 22.449 251.233 29.840
201903 20.900 254.202 27.457
201906 19.885 256.143 25.926
201909 20.003 256.759 26.017
201912 19.106 256.974 24.829
202003 23.556 258.115 30.477
202006 22.425 257.797 29.049
202009 20.690 260.280 26.546
202012 52.135 260.474 66.842
202103 143.800 264.877 181.300
202106 137.580 271.696 169.105
202109 137.367 274.310 167.234
202112 129.855 278.802 155.542
202203 118.111 287.504 137.193
202206 109.875 296.311 123.833
202209 99.745 296.808 112.228
202212 106.243 296.797 119.543
202303 88.229 301.836 97.617
202306 73.379 305.109 80.316
202309 63.985 307.789 69.424
202312 55.117 306.746 60.005
202403 30.207 312.332 32.298
202406 72.025 314.175 76.559
202409 68.085 315.301 72.112
202412 62.850 315.605 66.504
202503 54.045 319.799 56.437
202506 34.404 322.561 35.619
202509 30.954 324.800 31.826
202512 27.692 324.054 28.538
202603 25.449 330.213 25.737
202606 23.008 333.952 23.008

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN66.65 mean?
Filana Therapeutics (MEX:FLNA) has a Cyclically Adjusted Book per Share of MXN66.65 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Filana Therapeutics and its competitors.
Is Filana Therapeutics' Cyclically Adjusted Book per Share too high?
Filana Therapeutics' current Cyclically Adjusted Book per Share is MXN66.65. Overall, Filana Therapeutics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Filana Therapeutics' Cyclically Adjusted Book per Share compare to EDSA and GRCE?
Filana Therapeutics' Cyclically Adjusted Book per Share of MXN66.65 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Filana Therapeutics and its competitors. Filana Therapeutics's current Cyclically Adjusted Book per Share is MXN66.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Filana Therapeutics stock overvalued right now?
Filana Therapeutics (MEX:FLNA) has a current Cyclically Adjusted Book per Share of MXN66.65. The current Cyclically Adjusted Book per Share is MXN66.65. Filana Therapeutics' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Filana Therapeutics (MEX:FLNA), the current Cyclically Adjusted Book per Share is MXN66.65 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Filana Therapeutics Business Description

Other Exchanges FLNA:USAPX91:Germany
Address 6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
32GF Score

Get the complete analysis for MEX:FLNA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN15.92
Price